Leukemia, Lymphoid: all 1,772 studies

Page 18 of 18. Open to participants first (173), then studies with results posted, then the rest; newest registration first within each.

• Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody for Chronic Lymphocytic LeukemiaStatus unknownNCT00022880Phase 1
• Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Children With Acute Lymphoblastic LeukemiaCompletedNCT00022737Phase 3
• Combination Chemotherapy With or Without Donor Bone Marrow Transplantation in Treating Infants With Previously Untreated Acute Lymphoblastic LeukemiaCompletedNCT00022126Phase 2
• Vaccine Therapy in Preventing Flu in Children With Acute Lymphoblastic LeukemiaCompletedNCT00022035Not applicable
• Phase I/II Study of Genasense in Patients With Chronic Lymphocytic LeukemiaCompletedNCT00021749Phase 1/2
• Vaccine Therapy in Treating Patients With Acute Lymphoblastic LeukemiaTerminatedNCT00020670Early Phase 1
• Radiation Therapy to the Head or Intrathecal Chemotherapy Plus High Dose Cytarabine in Preventing CNS Disease in Children With Acute Lymphoblastic LeukemiaWithdrawnNCT00019409Phase 3
• Monoclonal Antibody Therapy in Treating Patients With Chronic Lymphocytic LeukemiaCompletedNCT00019032Phase 1
• Monoclonal Antibody Therapy in Treating Patients With Chronic Lymphocytic Leukemia, Lymphocytic Lymphoma, Acute Lymphoblastic Leukemia, or Acute Myeloid LeukemiaCompletedNCT00017472Phase 1
• Chlorambucil in Treating Patients With Advanced Chronic Lymphocytic LeukemiaStatus unknownNCT00017108Phase 3
• Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaCompletedNCT00016302Not applicable
• Flavopiridol, Cytarabine, and Mitoxantrone in Treating Patients With Acute LeukemiaCompletedNCT00016016Phase 1/2
• Comparison of Different Combination Chemotherapy Regimens in Treating Infants With Acute Lymphoblastic LeukemiaCompletedNCT00015873Phase 3
• Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic MalignanciesCompletedNCT00014235Not applicable
• Pilot Study of Non-Myeloablative, HLA-Matched Allogeneic Stem Cell Transplantation for Pediatric Hematopoietic MalignanciesCompletedNCT00013533Early Phase 1
• Rituximab Plus Interleukin-2 in Treating Patients With Hematologic CancerCompletedNCT00010192Phase 1
• Thalidomide With or Without Fludarabine in Treating Patients With Hematologic CancerTerminatedNCT00009984Phase 2
• Gemcitabine in Treating Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous LeukemiaCompletedNCT00006462Phase 2
• Alemtuzumab Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Lymphocytic LeukemiaCompletedNCT00006390Phase 2
• Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic CancerCompletedNCT00006251Phase 1/2
• Thalidomide in Treating Patients With Relapsed Chronic Lymphocytic LeukemiaCompletedNCT00006226Phase 2
• BMS-214662 in Treating Patients With Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myeloid LeukemiaCompletedNCT00006213Phase 1
• Chemotherapy in Treating Patients With Chronic Lymphocytic LeukemiaCompletedNCT00006097Phase 1/2
• Arsenic Trioxide in Treating Patients With Refractory or Relapsed Chronic Lymphocytic LeukemiaWithdrawnNCT00006090Phase 2
• Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Lymphoblastic LeukemiaCompletedNCT00006008Phase 2
• Comparison of Different Combination Chemotherapy Regimens in Treating Children With Acute Lymphoblastic LeukemiaCompletedNCT00005945Phase 3
• Study of Allogeneic Bone Marrow Transplantation Following Cyclophosphamide and Radiotherapy in Patients With Myelodysplastic Syndrome and Acute Leukemia Related to Fanconi's AnemiaCompletedNCT00005892Not applicable
• Gemcitabine in Treating Patients With Recurrent Chronic Lymphocytic LeukemiaCompletedNCT00005829Phase 2
• Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney CancerCompletedNCT00005799Not applicable
• Combination Chemotherapy in Treating Children With Acute Lymphoblastic LeukemiaCompletedNCT00005603Phase 3
• Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic LeukemiaCompletedNCT00005596Phase 3
• Combination Chemotherapy in Treating Children With Acute Lymphoblastic LeukemiaCompletedNCT00005585Phase 3
• Bryostatin + Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia or Relapsed Indolent Non-Hodgkin's LymphomaCompletedNCT00005580Phase 1
• Dolastatin 10 in Treating Patients With Indolent Lymphoma, Waldenstrom's Macroglobulinemia, or Chronic Lymphocytic LeukemiaCompletedNCT00005579Phase 2
• PS-341 in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia in Blast Phase, or Myelodysplastic SyndromeCompletedNCT00005064Phase 1
• Radiation Therapy and Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With High-Grade Lymphoma or Acute Lymphoblastic LeukemiaCompletedNCT00004898Phase 1/2
• Augmerosen Plus Fludarabine and Cytarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic LeukemiaCompletedNCT00004862Phase 1
• Monoclonal Antibody Therapy in Treating Patients With Recurrent Acute Lymphoblastic Leukemia or Non-Hodgkin's LymphomaStatus unknownNCT00004858Phase 1
• Fludarabine Followed by Alemtuzumab in Treating Patients With Chronic Lymphocytic LeukemiaCompletedNCT00004857Phase 2
• Chemotherapy in Treating Patients With Newly Diagnosed Chronic Lymphocytic LeukemiaCompletedNCT00004218Phase 3
• Monoclonal Antibody Therapy or Biological Therapy in Treating Patients With Chronic Lymphocytic Leukemia or Multiple Myeloma in Remission After ChemotherapyWithdrawnNCT00004040Phase 2
• Monoclonal Antibody Therapy, Cyclophosphamide, and Total-Body Irradiation Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Recurrent Acute Lymphocytic LeukemiaCompletedNCT00003870Phase 2
• Chemotherapy in Treating Patients With Previously Untreated Chronic Lymphocytic LeukemiaCompletedNCT00003829Phase 2
• Theophylline in Treating Patients With In Situ, Stage I, or Stage II Chronic Lymphocytic LeukemiaCompletedNCT00003808Phase 2
• Combination Chemotherapy in Treating Children With Very High Risk Acute Lymphocytic LeukemiaCompletedNCT00003783Phase 2
• Fludarabine With or Without Cyclophosphamide in Treating Patients With Chronic Lymphocytic LeukemiaCompletedNCT00003764Phase 3
• Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic LeukemiaCompletedNCT00003700Phase 2
• Pentostatin, Cyclophosphamide, and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Other B-cell CancersCompletedNCT00003658Phase 2
• 506U78 in Treating Patients With Chronic Lymphocytic Leukemia That Has Not Responded to Fludarabine or Alkylating AgentsCompletedNCT00003635Phase 2
• Flavopiridol in Treating Patients With Chronic Lymphocytic LeukemiaCompletedNCT00003620Phase 2
• 506U78 in Treating Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic LymphomaCompletedNCT00003545Phase 2
• Hormone Therapy Plus Chemotherapy in Treating Children With Acute Lymphoblastic LeukemiaStatus unknownNCT00003437Phase 3
• Fludarabine and Monoclonal Antibody Therapy in Treating Patients With Untreated B-cell Chronic Lymphocytic LeukemiaCompletedNCT00003248Phase 2
• Low-Dose Total Body Irradiation and Donor Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Patients With Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, or Multiple MyelomaCompletedNCT00003196Not applicable
• Bryostatin 1 Plus Cladribine in Treating Patients With Relapsed Chronic Lymphocytic LeukemiaCompletedNCT00003174Phase 1
• 506U78 in Treating Patients With Refractory Hematologic CancerCompletedNCT00002970Phase 2
• Chemotherapy With or Without Total-Body Irradiation Prior to Bone Marrow Transplantation in Treating Children With Acute Lymphoblastic LeukemiaTerminatedNCT00002961Phase 3
• Bone Marrow Transplantation in Treating Patients With Chronic Lymphocytic LeukemiaCompletedNCT00002844Phase 2
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Chronic Lymphocytic LeukemiaCompletedNCT00002838Phase 1/2
• Combination Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic LeukemiaCompletedNCT00002816Phase 3
• Combination Chemotherapy, Bone Marrow Transplantation, and Radiation Therapy in Treating Infants With Acute Lymphoblastic LeukemiaCompletedNCT00002785Phase 2
• Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic LeukemiaCompletedNCT00002744Phase 3
• Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia, Osteosarcoma, or Non-Hodgkin's LymphomaCompletedNCT00002738Phase 2
• Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic LeukemiaCompletedNCT00002704Phase 2
• Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic LeukemiaCompletedNCT00002700Phase 3
• Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Relapsed Acute Lymphocytic LeukemiaCompletedNCT00002638Phase 2
• Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic LeukemiaStatus unknownNCT00002532Phase 2
• Stem Cell Transplantation Compared With Standard Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia in First RemissionCompletedNCT00002514Phase 3
• Combination Chemotherapy in Treating Patients With Acute B-Lymphoblastic Leukemia or Non-Hodgkin's LymphomaCompletedNCT00002471Phase 2
• The Role of Cyclosporine in Blood Cell Transplants With T-Cell Add-Back for Blood CancersCompletedNCT00001873Phase 2
• Donor Th2 Cells to Prevent Graft-Versus-Host Disease in Bone Marrow TransplantsCompletedNCT00001830Phase 1
• Immunosuppressive Preparation Followed by Blood Cell Transplant for the Treatment of Blood Cancers in Older AdultsCompletedNCT00001637Phase 2

← Leukemia, Lymphoid overview